Institutional Ownership
Travere Therapeutics Inc
CUSIP 89422GAA5NOTE 2.250% 3/0TVTXQ1 2026
No Form 4 insider transactions ingested yet
Insider (Form 4) filings for Travere Therapeutics Inc are fetched from SEC EDGAR on a rolling basis. Check back shortly.